Creates structured equity research notes with thesis, valuation, risks, and rating justification. Use when initiating coverage, updating research opinions, or writing investment notes.
Scanned 9/12/2026
Install to Claude Code
npx -y skills add CaseMark/skills --skill writing-equity-research-notes --agent claude-codeInstalls into .claude/skills of the current project.
Are you the author of Writing Equity Research Notes?
Add the live security badge to your README — it updates automatically with every re-scan.
[](https://www.skillsdirectory.com/skills/casemark-writing-equity-research-notes)More formats (shields.io, HTML) on the badges page.
---
name: writing-equity-research-notes
language: en
description: Creates structured equity research notes with thesis, valuation, risks, and rating justification. Use when initiating coverage, updating research opinions, or writing investment notes.
tags:
- drafting
- equity-research
- risk
- investment
metadata:
author: casemark
practice_areas:
- Equity Research
- Investment Management
document_types:
- Written Document
skill_modes:
- Drafting
---
# Writing Equity Research Notes
## When To Use
- Initiating coverage on a new equity name
- Updating an existing rating or price target after earnings, guidance changes, or material events
- Writing a thematic or sector note that includes individual stock views
- Preparing internal investment committee memos supporting buy/sell/hold recommendations
- Responding to client requests for a written opinion on a specific security
## Inputs To Gather
- **Company identifiers**: Ticker, exchange, GICS sector/industry classification
- **Financial statements**: Last 3 years of income statement, balance sheet, and cash flow statement; most recent quarterly filing
- **Consensus estimates**: Street revenue, EPS, and EBITDA estimates for current and next two fiscal years
- **Valuation data**: Current share price, market cap, enterprise value, trading multiples (P/E, EV/EBITDA, EV/Revenue, FCF yield), and peer comparable set
- **Catalyst calendar**: Upcoming earnings date, product launches, regulatory decisions, index rebalance dates
- **Management commentary**: Latest earnings call transcript and investor day materials
- **Prior coverage**: Any existing internal notes, rating history, or price target changes on the name
- **Compliance constraints**: Firm-specific restricted list status, quiet period windows, and required disclosures [VERIFY]
## Workflow
1. **Define the note type and scope**
- Determine if this is an initiation, rating change, estimate revision, earnings recap, or thematic note
- Confirm the target audience (institutional clients, internal portfolio managers, or investment committee)
- Set the rating framework to use (e.g., Buy/Hold/Sell, Overweight/Equal-weight/Underweight) [VERIFY firm-specific rating scale]
2. **Build the investment thesis**
- State the core thesis in 1-2 sentences: what the market is missing or mispricing
- Identify 2-4 supporting pillars (revenue drivers, margin expansion levers, capital allocation, competitive moat)
- Quantify each pillar where possible (e.g., "We see 300bps of gross margin expansion from mix shift into software")
3. **Construct the financial model summary**
- Present key forecast assumptions: revenue growth, operating margin trajectory, capex intensity, and capital return
- Show a condensed P&L bridge from consensus to your estimates, highlighting where and why you differ
- Include a sensitivity table on the 1-2 variables that most move the valuation
4. **Derive valuation and price target**
- Select primary valuation methodology (DCF, comparable multiples, sum-of-the-parts, or blend)
- Justify the target multiple or discount rate with reference to historical trading range, peer set, and growth profile
- Calculate the price target and implied upside/downside from current price
- Present a bull/base/bear scenario framework with probability-weighted expected value if appropriate
5. **Identify risks and mitigants**
- List the top 3-5 risks to the thesis, each with a brief mitigant or monitoring trigger
- Distinguish between company-specific risks (execution, balance sheet, key-person) and macro/sector risks (regulatory, cyclical, FX)
- Flag any binary event risks (FDA decision, litigation outcome, contract renewal) with expected timing
6. **Draft the note**
- Open with a header block: ticker, rating, price target, current price, market cap, and key metrics
- Lead with an executive summary (3-5 bullet points capturing rating, target, thesis, and key catalyst)
- Organize body sections: Thesis, Financial Overview, Valuation, Risks, Appendix (model tables, comp tables)
- Use concise, assertion-driven language; avoid hedging without substance
7. **Add compliance disclosures**
- Include required ownership/conflict disclosures per firm policy and applicable regulation [VERIFY — FINRA 2241, MiFID II, or firm-specific requirements]
- Add analyst certification language if required
- Note any material non-public information restrictions or quiet period status
## Output
The final research note should contain:
- **Header block**: Ticker | Rating | Price Target | Current Price | Market Cap | Sector
- **Executive summary**: 3-5 bullets with the actionable conclusion up front
- **Investment thesis**: Narrative with quantified supporting pillars
- **Financial summary**: Key estimates table, consensus comparison, sensitivity analysis
- **Valuation**: Methodology, target derivation, scenario analysis
- **Risk factors**: Prioritized list with mitigants
- **Appendix**: Detailed model, comparable company table, disclosures
Format as a professional research note with consistent heading hierarchy, right-aligned data tables, and source citations for third-party data.
## Quality Checks
- [ ] Rating, price target, and implied return are internally consistent with the valuation methodology
- [ ] Estimates in the note match the financial model; no stale or contradictory figures
- [ ] Every quantitative claim has a sourced data point or is explicitly labeled as an estimate/assumption
- [ ] Bull/base/bear scenarios span a credible range and the base case aligns with the price target
- [ ] Risk factors are specific to this company and thesis — no generic boilerplate risks
- [ ] Compliance disclosures match the firm's current requirements [VERIFY]
- [ ] Tone is assertion-driven and professional; no unsupported superlatives ("best-in-class," "massive opportunity") without evidence
- [ ] Note is self-contained: a reader unfamiliar with the name can understand the thesis without external documents
Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.
No comments yet. Be the first to comment!